Maximus (MMS) came out with quarterly earnings of $1.61 per share, beating the Zacks Consensus Estimate of $1.39 per share. This compares to earnings of $1.34 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 15.83%. A quarter ago, it was expected that this government health services provider would post earnings of $1.47 per share when it actually produced earnings of $1.46, delivering a surprise of -0.68%.Over the last four qua ...

FOR IMMEDIATE RELEASE CONTACT: James Francis, VP - IR Jessica Batt, VP - IR & ESG Date: February 6, 2025 IR@maximus.com Maximus Reports Fiscal Year 2025 First Quarter Results Raises FY25 Earnings Guidance While Securing Favorable Outcomes on Key Rebids (Tysons, Va. - February 6, 2025) - Maximus (NYSE: MMS), a leading provider of government services worldwide, reported financial results for the three months ending December 31, 2024. Highlights for the first quarter of fiscal year 2025 include: "Along with st ...

Maximus, Inc. (MMS) shares have returned 8% in the past month, and we believe that the stock has the potential to sustain its momentum in the near term.MMS carries a Zacks Rank #2 (Buy) and a VGM Score of A at present. Our research shows that stocks with a VGM Score of A or B, when combined with a Zacks Rank #1 (Strong Buy) or 2, offer the best investment opportunities for investors. Thus, the company appears to be a compelling investment proposition.The Zacks Consensus Estimate for fiscal 2025 earnings is ...

Maximus (MMS) has been on a downward spiral lately with significant selling pressure. After declining 21.8% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.How to Determine if a Stock is OversoldWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is ...

Maximus (MMS) has been on a downward spiral lately with significant selling pressure. After declining 16.2% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.Here is How to Spot Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is ove ...

Financial Data and Key Metrics Changes - For fiscal year 2024, consolidated revenue increased by 8.2% to $5.31 billion, with organic revenue growth of 8.8% [30][29] - Adjusted earnings per share (EPS) for fiscal year 2024 was $6.11, a significant increase from $3.83 in the prior year [30][29] - Free cash flow exceeded $400 million, representing nearly 80% growth over the prior year [29][36] - Adjusted EBITDA margin for fiscal year 2024 was 11.6%, compared to 9.1% in the prior year [31][30] Business Line Data and Key Metrics Changes - US Federal Services segment revenue increased by 13.9% to $2.74 billion, driven by volume growth on expanded clinical programs [33] - US Services segment revenue grew by 5.5% to $1.91 billion, supported by strong performance in core Medicaid-related activities [34] - Outside the US segment revenue decreased by 4.6% to $657 million, impacted by prior year divestitures [35] Market Data and Key Metrics Changes - The total pipeline as of September 30 was $54.3 billion, up from $44.1 billion in the previous quarter [23] - Approximately 68% of the total pipeline is attributed to the US Federal Services segment [23] - The book-to-bill ratio for the trailing 12-month period was approximately 0.4 times, reflecting lower-than-normal rebid activity [22] Company Strategy and Development Direction - The company is focused on technology modernization and has secured contracts that align with this strategic priority, including a $128 million task order with the IRS [16] - The company aims for a compound annual growth rate of 5% over the next three years, consistent with mid-single-digit organic growth targets [15] - The company is committed to maintaining a disciplined approach to capital allocation, prioritizing organic investments and strategic acquisitions [38][39] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate the transition to a new administration, emphasizing its established role as a trusted partner to governments [12][26] - The company anticipates a return to a more normal volume of rebids and procurement activity in fiscal year 2025 [22][62] - Management highlighted the importance of continuing to deliver high-quality services to over 100 million Americans, particularly in entitlement programs [55] Other Important Information - The company repurchased approximately 0.9 million shares for about $73 million during fiscal year 2024, with an additional 0.5 million shares repurchased post-year-end [37] - The company is currently involved in legal proceedings regarding the CMS CCO contract, with a stay of award until March 15, 2025 [22] Q&A Session Summary Question: Update on the CCO contract - Management confirmed that the GAO upheld a protest regarding the procurement, and the administration has indicated that award announcements will not occur until March 2025 [53] Question: Comparison of Trump 1.0 and Trump 2.0 administrations - Management noted that the current administration has more experience, which may reduce delays in procurement processes compared to the previous administration [54] Question: Clarification on revenue guidance and margins - Management explained that fiscal year 2024 margins benefited from excess volumes that are not expected to recur in fiscal year 2025, leading to a more normalized margin outlook [58] Question: Backlog and book-to-bill dynamics - Management indicated that the book-to-bill ratio is expected to trend towards 1.0 as rebid activity normalizes in fiscal year 2025 [62]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark one) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2024 ☐ TRANSITIONAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________to__________. Commission file number: 1-12997 Maximus, Inc. Title of each class Trading Symbol(s) Name of each exchange on which regist ...

| --- | --- | |---------------------------------------------------|-------| | | | | | | | | | | | | | | | | Fiscal 2024 Year End | | | Earnings Call | | | Bruce Caswell President & Chief Executive Officer | | | November 21, 2024 | | Forward-looking Statements & Non-GAAP Information These slides should be read in conjunction with our most recent quarterly earnings press release, along with listening to or reading a transcript of management comments from our most recent quarterly earnings conference call. Thi ...

Maximus, Inc. (MMS) reported mixed fourth-quarter fiscal 2024 results. Earnings marginally missed the Zacks Consensus Estimate, but revenues beat the Zacks Consensus Estimate.Quarterly adjusted earnings of $1.46 per share marginally lagged the Zacks Consensus Estimate but increased 13.2% on a year-over-year basis. Revenues of $1.32 billion beat the consensus mark by 1.8% and rose 4.4% from the year-ago quarter.Segmental Revenues of MaximusThe U.S. Federal Services segment’s revenues of $675 million rose 9.4 ...

For the quarter ended September 2024, Maximus (MMS) reported revenue of $1.32 billion, up 4.4% over the same period last year. EPS came in at $1.46, compared to $1.29 in the year-ago quarter.The reported revenue represents a surprise of +1.77% over the Zacks Consensus Estimate of $1.29 billion. With the consensus EPS estimate being $1.47, the EPS surprise was -0.68%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their ne ...